For all media enquiries please email [email protected] or contact the Novartis switchboard at +61 2 9805 3555.
If your media enquiry relates to an oncology product, please contact Aldina Aljukic on 0437 444 742.
Disruption in supply - Estradot, Estalis Continuous and Estalis Sequi in Australia
Novartis/Sandoz has received an allocation of stock of Estradot, Estalis Continuous and Estalis Sequi in November 2017, for Australia. We are in the process of re-stocking wholesalers.
We continue to work with the manufacturer (an overseas independent third-party) to ensure stock of these products for Australian patients, however we cannot rule out the possibility of further disruptions in supply. We urge all patients to consider this possibility and consult their treating physician to discuss options for their ongoing treatment.
For enquiries please contact Novartis Medical Information on 1800 671 203 or [email protected]